Eric Chen

In this lively discussion, Steven McClurg, CIO at Valkyrie and Canary, and Eric Chen, co-founder of Injective Labs, dive into the booming world of crypto ETFs. They reveal an exciting timeline for the potential approval of 20-50 new crypto ETFs. The conversation touches on innovations in financial products, the importance of staking yields, and how traditional finance is embracing cryptocurrency. They also share insights on the significance of MicroStrategy's S&P 500 inclusion and the future of decentralized finance.

Steven McClurg, CEO of Canary and pioneer of Bitcoin futures on NASDAQ, teams up with Eric Chen, CEO of Injective, who is reshaping the financial landscape with cutting-edge consumer applications. They dive into how ETF flows influence market trends and discuss groundbreaking developments like Solana’s NASDAQ listing. The duo also tackles the evolving job market and its impact on unemployment rates, alongside the innovative strides in decentralization, including the potential of Ethereum ETFs. Their insightful analysis brings hope for a bullish future in crypto.

In this discussion, Eric Chen, co-founder and CEO of Injective Labs, delves into the groundbreaking launch of an AI index perpetual market on Helix. He highlights the collaboration between traditional finance and decentralized finance, emphasizing the push for tokenization of classic assets. Chen also sheds light on Helix's unique integration of AI-focused projects with Web2 and Web3 elements. The conversation touches on the future of finance, the impact of evolving regulations, and the necessity for diversification in today's AI-driven investment landscape.